2017-001598-18
A study to determine the safety and efficacy of duloxetine in the treatment of children and adolescents with depression.
Eli Lilly and Company Limited·EU Clinical Trials Register
Study focus
- Disease/Condition
- Major Depressive Disorder
Sponsor & location
- Primary sponsor
- Eli Lilly and Company Limited
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
- Children of site personnel directly affiliated with this study and/or their immediate families.
ICD-10 classifications
Recurrent depressive disorder, current episode mildDepressive episode, unspecifiedDepressive episodeMild depressive episodeRecurrent depressive disorder, current episode moderate
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2017-001598-18
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2017-001598-18 through Pure Global AI's free database. This phase not specified trial is sponsored by Eli Lilly and Company Limited and is currently status unknown. The study focuses on Major Depressive Disorder.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.